Mr. Dentinger, along with his business partner Ismael Hidalgo, co-founded Absorption Systems in 1996. The original premise, still a guiding principle, was that validated, reliable preclinical test systems could identify drug candidates with appropriate drug-like properties and help predict success in the clinic. Mr. Dentinger, who is responsible for the business side of the company, has overseen consistent organic growth of top-line revenue and bottom-line profit for fifteen years. The company has gradually expanded from the original emphasis on drug absorption to a much more diversified portfolio of contract pharmaceutical services and innovative service platforms.
Mr. Dentinger’s undergraduate degree in pharmacology from the University of California, Santa Barbara was followed by enough graduate work to convince him that he would rather “sell” science than “do” science. His experience in business development and licensing in biotechnology and clinical research, combined with his scientific training, were the perfect foundation for leadership of a company such as Absorption Systems. Mr. Dentinger and Dr. Hidalgo were 2002 recipients of the Ernst and Young Entrepreneur of the Year award.